I-Melon Emuncu

Umxholo

• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

I-melon melitter yimifuno esetyenziswa e-India nakwamanye amazwe ase-Asiya. Iziqhamo nembewu zisetyenziselwa ukwenza amayeza.

Abantu basebenzisa i-melon ekrakra yeswekile, ukutyeba kakhulu, iingxaki zesisu kunye namathumbu, kunye nezinye iimeko ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe I-MELON ENGCONO zezi zilandelayo:

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Ukusebenza kwezemidlalo. Uphando lwakwangoko lubonisa ukuba ukuthatha i-melon extract kunokunciphisa ukudinwa kubantu abathatha inxaxheba kuqeqesho lomzimba olunamandla kumaqondo aphezulu obushushu.
• Seswekile. Uphando luyaphikisana kwaye aluhambelani. Olunye uphando lubonisa ukuba ukuthatha i-melon ekrakra kunokunciphisa amanqanaba eswekile yegazi kunye ne-HbA1c esezantsi (umlinganiso wolawulo lweswekile egazini ngokuhamba kwexesha) kubantu abanesifo seswekile sesi-2. Kodwa ezi zifundo zineziphene. Kwaye ayilulo lonke uphando oluvumayo. Izifundo ezikumgangatho ophezulu ziyafuneka.
• Isifo seswekile. Uphando lwakwangoko lubonisa ukuba i-melon ekrakra ayinciphisi iswekile yegazi kubantu abane-prediabetes.
• Osteoarthritis. Uphando lwakwangoko lubonisa ukuba i-melon ekrakra inciphisa inani lamayeza eentlungu afunwa ngabantu abane-osteoarthritis. Kodwa akubonakali ukuphucula iimpawu.
• Ukuhlelwa kweempawu ezonyusa umngcipheko wesifo seswekile, isifo sentliziyo, kunye nokubetha (isifo se-metabolic syndrome).
• Uhlobo lwesifo sokukrala kwamathumbu (ulcerative colitis).
• Intsholongwane kaGawulayo / uGawulayo.
• Ukunyanzeliswa (dyspepsia).
• Usulelo lwamathumbu ngama-parasites.
• Amatye eentso.
• Isifo sesibindi.
• I-Scaly, isikhumba esilumkileyo (psoriasis).
• Izilonda esiswini.
• Ukuphilisa amanxeba.
• Ezinye iimeko.

Ubungqina obuninzi bufunekayo ukukala ukusebenza kweemelon ekrakra kwezi zinto zisetyenziswayo.

I-melon melon inekhemikhali esebenza njenge-insulin ukunceda ukunciphisa amanqanaba eswekile yegazi.

Xa kuthathwa ngomlomo: Ubumuncu obukrakra UKHUSELEKO OLUNOKWENZEKA kubantu abaninzi xa bethathwe ngomlomo ixesha elifutshane (ukuya kuthi ga kwiinyanga ezi-4). I-melon melon inokubangela isisu esibuhlungu kwabanye abantu. Ukhuseleko lwexesha elide lokusetyenziswa kwemelon ekrakra alwaziwa.

Xa isetyenziswa eluswini: Akukho lwazi lwaneleyo oluthembekileyo lokwazi ukuba i-melon ekrakra ikhuselekile xa ifakwe kulusu. Inokubangela irhashalala.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Ubumuncu obukrakra OKUNGENZEKA UKHUSELEKILE xa ithathwa ngomlomo ngexesha lokukhulelwa. Ezinye iikhemikhali ezikwi-melon ekrakra zinokuqala ukopha exesheni kwaye zibangele ukuqhomfa kwizilwanyana. Akwanelanga okwaziwayo malunga nokukhuseleka kokusebenzisa imelon ekrakra ngexesha lokuncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

SeswekileI-melon melon inganciphisa amanqanaba eswekile yegazi. Ukuba unesifo seswekile kwaye uthathe amayeza ukunciphisa iswekile yegazi, ukongeza i-melon ekrakra kunokwenza iswekile yegazi lakho lihle kakhulu. Jonga eswekile yegazi lakho ngononophelo.

Ukusilela kweGlucose-6-phosphate dehydrogenase (G6PD)Abantu abanesiphene se-G6PD banokuphuhlisa "ukuthanda" emva kokutya imbewu yeemelon ekrakra. I-Favism yimeko ebizwa ngegama le-fava bean, ekucingelwa ukuba ibangela "igazi elidiniweyo" (i-anemia), intloko ebuhlungu, umkhuhlane, iintlungu zesisu, kunye ne-coma kubantu abathile. Imichiza efumaneka kwimbewu ye-melon ekrakra inxulumene neekhemikhali kwiimbotyi ze-fava. Ukuba unesiphene se-G6PD, thintela imelon ekrakra.

Ugqirha: Kukho inkxalabo yokuba i-melon ekrakra inokuphazamisana nolawulo lweswekile yegazi ngexesha nasemva kotyando. Yeka ukusebenzisa i-melon ekrakra ubuncinci iiveki ezi-2 ngaphambi kotyando olucwangcisiweyo.

Iphakathi

Lumka ngale nhlanganisela.

Amayeza eswekile (iziyobisi zeAntidiabetes)

I-melon melitter inokunciphisa amanqanaba eswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ukuthatha i-melon ekrakra kunye namayeza eswekile kunokubangela ukuba iswekile yegazi yakho ibe sezantsi kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza eswekile aquka i-glimepiride (Amaryl), i-glyburide (iDiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-repaglinide (i-Prandin), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol) kunye nezinye.

Amayeza ashukunyiswa yimpompo kwiiseli (P-Glycoprotein Substrates)

Amanye amayeza ahanjiswa ziimpompo kwiiseli. Isithako esikwimelon ekrakra singenza ezi mpompo zingasebenzi kwaye zonyuse ukuba amanye amayeza ahlala ixesha elingakanani emzimbeni. Oku kunokunyusa ukusebenza kakuhle okanye iziphumo ebezingalindelekanga zamanye amayeza.
Amanye amayeza ashukunyiswa ziimpompo kwiiseli zibandakanya i-rivaroxaban powder (Xarelto), apixaban (Eliquis), linagliptin (Tradjenta), etoposide (Toposar), paclitaxel (Taxol), vinblastine (Velban), vincristine (Vincasar), itraconazole (Sporanox), amprenavir (Agenerase), indinavir (Crixivan), nelfinavir (Viracept), saquinavir (Invirase), cimetidine (Tagamet), ranitidine (Zantac), diltiazem (Cardizem), verapamil (Calan), corticosteroids, erythromadine (Erythromadine) (Allegra), cyclosporine (Sandimmune), loperamide (Imodium), quinidine (Quinidex), kunye nabanye.

Iherbs kunye nezongezo ezinokunciphisa iswekile yegazi

I-melon melon inganciphisa amanqanaba eglucose egazini. Ukuyisebenzisa ngamanye amayeza okanye izongezo ezinefuthe elifanayo kunokubangela amanqanaba eswekile yegazi ukuba awe phantsi kakhulu. Amanye amayeza kunye nezongezo ezinokuhlisa iswekile yegazi zibandakanya i-alpha-lipoic acid, i-chromium, i-devil's claw, i-fenugreek, igalikhi, i-guar gum, i-chestnut yehashe, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, nezinye.

Akukho kunxibelelana kwaziwayo nokutya.

Idosi efanelekileyo yemelon ekrakra ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha, akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi zemelon ekrakra. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa.

Ikhukhamba yaseAfrika, iAmpalaya, iBhalsam Pear, iBhalsam-iapile, iBhalsambirne, iBhalsalam, iBhalsamo, iBitter Apple, Ikrakra elibi Mormordicae Grosvenori, Karavella, Karela, Kareli, Kathilla, Kerala, Korolla, Kugua, Kuguazi, K'u-Kua, Lai Margose, Margose, Melón Amargo, Melon Amer, Momordica, Momordica charantia, Momordica murcata, Momordique, Paroka, Pepino Montero , Poire Balsamique, Pomme de Merveille, P'u-T'ao, Sorosi, Sushavi, Ucche, Imifuno ye-insulin, Ikhukhamba yasendle.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. I-Kwak JJ, i-Yook JS, i-Ha MS. Izinto ezinokubakho kwiipheripheral kunye nokudinwa okuphakathi kwiimbaleki eziqeqeshwe ngamandla kubushushu obuphezulu: isifundo somqhubi kunye noMomordica charantia (imelon ekrakra). J I-Immunol Res. Ngo-2020; 2020: 4768390. Jonga i-abstract.
2. ICortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG, González-Ortiz M, Méndez-Del Villar M. Momordica charantia yolawulo iphucula ukugcinwa kwe-insulin kuhlobo lwe-2 yeswekile. J Med Ukutya. 2018; 21: 672-7. ikhonkco: 10.1089 / jmf.2017.0114. Jonga i-abstract.
3. UPeter EL, uKasali FM, uDeyno S, et al. I-Momordica charantia L. yehlisa i-glycaemia ephezulu kuhlobo lwe-2 yezigulana zesifo seswekile: Ukuphononongwa kwenkqubo kunye nohlalutyo lwe-meta. J U-Ethnopharmacol. Ngo-2019; 231: 311-24. ikhonkco: 10.1016 / j.jep.2018.10.033. Jonga i-abstract.
4. Soo ngoMeyi L, Sanip Z, Ahmed Shokri A, Abdul Kadir A, Md Lazin MR. Iziphumo zeMomordica charantia (imelon ekrakra) ukuxhaswa kwizigulana ezineedolo osteoarthritis: Isilingo esilawulwa ngamehlo esisodwa. Gcwalisa uQeqesho lweKlinikhi yoNyango. 2018; 32: 181-6. ikhonkco: 10.1016 / j.ctcp.2018.06.012. Jonga i-abstract.
5. Yue J, Ilanga Y, Xu J, et al. I-Cucurbitane triterpenoids evela kwisiqhamo se-Momordica charantia L. kunye ne-anti-hepatic fibrosis kunye nemisebenzi ye-hepatoma. I-Phytochemistry. Ngo-2019; 157: 21-7. ikhonkco: 10.1016 / j.phytochem.2018.10.009. Jonga i-abstract.
6. UWen JJ, uGao H, uHu JL, et al. Iipolysaccharides ezivela kwiMomordica charantia enegwele ziyayomeleza ukutyeba kakhulu kwiigundane ezityebileyo. Umsebenzi wokutya. Ngo-2019; 10: 448-57. ikhonkco: 10.1039 / c8fo01609g. Jonga i-abstract.
7. UKonishi T, uSatsu H, uHatsugai Y, et al. Isiphumo sokuthintela ukukhutshwa kwe-melon ekrakra kwimisebenzi ye-P-glycoprotein kwiiseli zesisu zeCaco-2. UBr J Pharmacol. Ngo-2004; 143: 379-87. Jonga i-abstract.
8. UBoone CH, uStout JR, uGordon JA, et al. Iziphumo ezibi zesiselo esinencindi yemelon ekrakra (CARELA) kwi-postprandial glycemia phakathi kwabantu abadala be-prediabetic. Iswekile enesondlo. Ngo-2017; 7: 244. Jonga i-abstract.
9. UAlam MA, u-Uddin R, uS Subhan N, uRahman MM, uJain P, uReza HM. Indima yokuxhamla yokuncedisa i-melon ukunyusa ukukhuluphala kunye neengxaki ezinxulumene nesifo se-metabolic syndrome. J Lipids. Ngo-2015; ngo-2015: 496169. Jonga i-abstract.
10. I-Somasagara RR, i-Deep G, i-Shrotriya S, i-Patel M, i-Agarwal C, i-Agarwal R. I-Bitter melon ijolise ekujongeni iindlela zeemolekyuli eziphantsi koxinzelelo lwe-gemcitabine kwiiseli zomhlaza wepancreatic. Int J Oncol. Ngo-2015; 46: 1849-57. Jonga i-abstract.
11. URahman IU, uKhan RU, uRahman KU, uBashir M. Lower hypoglycemic kodwa iziphumo eziphezulu ze-antiatherogenic zemelon ekrakra kune-glibenclamide yohlobo lwe-2 yezigulana ezinesifo seswekile. Isondlo J. 2015; 14: 13. Jonga i-abstract.
12. UBhattacharya S, uMuhammad N, uSteele R, uPeng G, uRay RB. Indima yokuqaqanjelwa mzimba kwincindi ekrakra yemelon inhibition yentloko kunye nentamo squamous cell carcinoma ukukhula. Ukhenketho. Ngo-2016; 7: 33202-9. Jonga i-abstract.
13. I-Yin RV, uLee NC, uHirpara H, uPhung OJ. T.Impembelelo ye-melon ekrakra (Mormordica charantia) kwizigulana ezinesifo seswekile: uphononongo lwenkqubo kunye nohlalutyo lweemeta. Iswekile enesondlo. Ngo-2014; 4: 1414. Jonga i-abstract.
14. Dutta PK, Chakravarty AK, CHowdhury US, kunye Pakrashi SC. I-Vicine, i-toism-inducing toxin evela kwi-Momordica charantia Linn. iimbewu. Indiya J Chem 1981; 20B (Agasti): 669-671.
15. I-Srivastava Y. Antidiabetic kunye ne-adaptogenic yeempawu zeMomordica charantia: Uvavanyo kunye novavanyo lweklinikhi. UPhytother Res 1993; 7: 285-289.
16. I-Raman A kunye neLau C. Iipropathi zokulwa isifo seswekile kunye ne-phytochemistry ye-Momordica charantia L. (Cucurbitaceae). Unyango lwePhytomedicine 1996; 2: 349-362.
17. UStepka W, uWilson KE, kunye noMadge GE. Ukuphanda ukungabinako ukuchuma eMomordica. ULloydia 1974; 37: 645.
18. IBaldwa VS, iBhandara CM, iPangaria A, kunye et al. Uvavanyo lweklinikhi kwizigulana ezinesifo seswekile esine-insulin efana nekhompawundi efunyenwe kumthombo wesityalo. Upsala J Med Sci 1977; 82: 39-41.
19. Takemoto, D.J, Dunford, C., kunye noMcMurray, M. M.I-cytotoxic kunye ne-cytostatic ifuthe le-melon ekrakra (Momordica charantia) kwii-lymphocyte zabantu. Ityhefu 1982; 20: 593-599. Jonga i-abstract.
20. UDixit, V. P., Khanna, P., kunye noBhargava, S. K. Iziphumo zeMomordica charantia L.isiqhamo sesicatshulwa somsebenzi wenja. UPlanta Med 1978; 34: 280-286. Jonga i-abstract.
21. I-Aguwa, C. N. kunye neMittal, G. C. Iziphumo zeAortifacient yeengcambu zeMomordica angustisepala. J U-Ethnopharmacol. Ngo-1983; 7: 169-173. Jonga i-abstract.
22. U-Akhtar, M. S. Uvavanyo lwe-Momordica charantia Linn (Karela) ipowder kwizigulana ezinesifo seswekile sokukhula. J Pak.I-Med Assoc 1982; 32: 106-107. Jonga i-abstract.
23. Welihinda, J., Arvidson, G., Gylfe, E., Hellman, B., kunye noKarlsson, E. Umsebenzi okhupha i-insulin yesityalo se-tropical momordica charantia. Umthetho weBiol Med Ger ngo-1982; 41: 1229-1240. Jonga i-abstract.
24. U-Chan, W. Y., Tam, P. P., kunye no-Yeung, H. W. Ukupheliswa kokukhulelwa kwangoko kwimouse yi-beta-momorcharin. Ukuthintela inzala ngo-1984; 29: 91-100. Jonga i-abstract.
25. Takemoto, D.J, Jilka, C., kunye noKresie, R. Ukucoca kunye nokubonakaliswa kwento ye-cytostatic evela kwi-melon ebabayo Momordica charantia. Lungiselela. I-Biochem 1982; 12: 355-375. Jonga i-abstract.
26. Wong, C. M., Yeung, H. W., kunye noNg, T. B. Ukuvavanywa kweTrichosanthes kirilowii, Momordica charantia kunye neCucurbita maxima (usapho lweCucurbitaceae) yezixhobo ezinomsebenzi wokuchasana ne-antilipolytic. J U-Ethnopharmacol. Ngo-1985; 13: 313-321. Jonga i-abstract.
27. Ng, T. B., Wong, C. M., Li, W. W., kunye no-Yeung, H. W. Ukuzahlula kunye nokubonakaliswa kwe-lectin ebophayo ye-galactose enemisebenzi ye-insulinomimetic. Ukusuka kwimbewu yomthi okrakra uMomordica charantia (uSapho lweCucurbitaceae). I-Int J Peptide Protein Res 1986; 28: 163-172. Jonga i-abstract.
28. Ng, T. B., Wong, C. M., Li, W. W., kunye no-Yeung, H. W. I-molecule efana ne-insulin kwiimbewu zeMomordica charantia. J U-Ethnopharmacol. Ngo-1986; 15: 107-117. Jonga i-abstract.
29. Liu, H. L., Wan, X., Huang, XF, kunye noKong, L.Y. Biotransformation ye-sinapic acid eyenziwe nguMomordica charantia peroxidase. J Agric Ukutya Chem 2-7-2007; 55: 1003-1008. Jonga i-abstract.
30. I-Yasui, Y., Hosokawa, M., Kohno, H., Tanaka, T., kunye neMiyashita, K. Troglitazone kunye ne-9cis, 11trans, 13trans-conjugated linolenic acid: ukuthelekisa i-antiproliferative kunye ne-apoptosis-ifuthe kwiziphumo ezahlukeneyo imigca yeseli. I-Chemotherapy ngo-2006; 52: 220-225. Jonga i-abstract.
31. UNerurkar, PV, Lee, YK, Linden, EH, Lim, S., Pearson, L., Frank, J., kunye noNerurkar, VR Lipid ukwehlisa iziphumo zeMomordica charantia (Bitter Melon) kwi-HIV-1-protease inhibitor ephathwe iiseli ze-hepatoma zabantu, i-HepG2. UBr J Pharmacol 2006; 148: 1156-1164. Jonga i-abstract.
32. UShekelle, P.G, Hardy, M., Morton, S., Coulter, I., Venuturupalli, S., Favreau, J., kunye noHilton, L. K. Ngaba amayeza e-Ayurvedic eswekile ayasebenza? J Fam Ukukhetha. Ngo-2005; 54: 876-886. Jonga i-abstract.
33. UNerurkar, P. V., Pearson, L., Efird, J. T., Adeli, K., Theriault, A. G., kunye noNerurkar, V. J Amanqatha 2005; 135: 702-706. Jonga i-abstract.
34. USenanayake, GV, Maruyama, M., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., kunye no-Ohta, H. Iziphumo ze-melon ebabayo (Momordica charantia) Iiparameter zeserum kunye nesibindi se-lipid kwii-hamsters zondla i-cholesterol-kunye nokutya okune-cholesterol. J Nutr Sci Vitaminol. (Tokyo) 2004; 50: 253-257. Jonga i-abstract.
35. UKohno, H., Yasui, Y., Suzuki, R., Hosokawa, M., Miyashita, K., kunye noTanaka, T.Imbewu yeoyile yembewu etyebileyo kwi-conjugated linolenic acid kwi-melon ekrakra inqanda i-azoxymethane-indened rat colon carcinogenesis ngokunyuka yokubonakaliswa kwe-colonic PPARgamma kunye notshintsho lolwakhiwo lwe-lipid. Int J Umhlaza 7-20-2004; 110: 896-901. Jonga i-abstract.
36. I-Senanayake, GV, Maruyama, M., Shibuya, K., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., kunye no-Ohta, H. Iziphumo zemelon ekrakra ( I-Momordica charantia) kwinqanaba le-serum kunye nesibindi se-triglyceride kwiigundane. J U-Ethnopharmacol 2004; 91 (2-3): 257-262. Jonga i-abstract.
37. I-Pongnikorn, S., Fongmoon, D., Kasinrerk, W., kunye neLimtrakul, P. N. Iziphumo zemelon ekrakra (Momordica charantia Linn) kwinqanaba kunye nokusebenza kweeseli zokubulala zendalo kwizigulana ezinomhlaza womlomo wesibeleko ezine-radiotherapy. UJ Med Assoc Thai. Ngo-2003; 86: 61-68. Jonga i-abstract.
38. URebultan, S. P. Unyango lwenyibilikunyanga: unyango lokulinga losulelo lwe-HIV. I-AIDS e-Asia 1995; 2: 6-7. Jonga i-abstract.
39. U-Lee-Huang, S., Huang, PL, Sun, Y., Chen, HC, Kung, HF, Huang, PL, kunye noMurphy, WJ Inhibition we-MDA-MB-231 ithumba lesifuba somntu kunye ne-HER2 expression by anti-tumor iiarhente zeGAP31 kunye neMAP30. I-Anticancer Res 2000; 20 (2A): 653-659. Jonga i-abstract.
40. UWang, YX, Jacob, J., Wingfield, PT, Palmer, I., Stahl, SJ, Kaufman, JD, Huang, PL, Huang, PL, Lee-Huang, S., kunye noTorchia, i-DA yokulwa i-HIV kunye nokulwa Iprotheni ye-MAP30, i-30 kDa yohlobo olunye-I-RIP, yabelana ngolwakhiwo lwesibini olufanayo kunye ne-beta-sheet topology ngetyathanga le-ricin, uhlobo-II RIP. Iprotein Sci. Ngo-2000; 9: 138-144. Jonga i-abstract.
41. UWang, YX, uNeamati, uN., UJacob, uJ., UPalmer, u-I, uStahl, uSJ, uKaufman, uJD, uHuang, u-PL, uHuang, u-PL, uWinslow, u-HE, uPommier, u-Y., UWingfield, uPT, uLee- IHuang, S., Bax, A., kunye neTorchia, i-DA Isisombululo sesakhiwo se-anti-HIV-1 kunye ne-anti-tumor protein MAP30: ukuqonda kwesakhiwo kwimisebenzi yayo emininzi. Iseli 11-12-1999; 99: 433-442. Jonga i-abstract.
42. I-Basch E, i-Gabardi S, i-Ulbricht C. I-melon melon (iMomordica charantia): uphononongo lokusebenza kunye nokhuseleko. NdinguJ J Syst Pharm 2003; 60: 356-9. Jonga i-abstract.
43. Kwi-AM, Villarruz MV, Jimeno CA, et al. Iziphumo zeMomordica charantia yokulungiselela i-capsule kulawulo lwe-glycemic kuhlobo lwe-2 yeswekile yesifo seswekile ifuna ukuqhubeka kokufunda. J Ikliniki ye-Epidemiol 2007; 60: 554-9. Jonga i-abstract.
44. I-Shibib BA, i-Khan LA, i-Rahman R.Umsebenzi we-Hypoglycaemic we-Coccinia indica kunye ne-Momordica charantia kwiigundane zeswekile: uxinzelelo lwe-hepatic gluconeogenic enzymes glucose-6-phosphatase kunye ne-fructose-1,6-bisphosphatase kunye nokuphakama kwesibindi kunye neseli ebomvu i-enzyme iswekile-6-phosphate dehydrogenase. Biochem J 1993; 292: 267-70. Jonga i-abstract.
45. UAhmad N, uHassan MR, uHalder H, uBennoor KS. Iziphumo zeMomordica charantia (Karolla) izicatshulwa ngokuzila ukutya kunye nasemva kwamanqanaba e-serum glucose kwizigulana ze-NIDDM (ezingabonakaliyo). IBhunga lase-Bangladesh Med Res iBhunga 1999; 25: 11-3. Jonga i-abstract.
46. UAslam M, uStockley IH. Unxibelelwano phakathi kwesithako se curry (karela) kunye neziyobisi (i-chlorpropamide). ILancet 1979: 1: 607. Jonga i-abstract.
47. UAnila L, Vijayalakshmi NR. Iziphumo eziluncedo ze-flavonoids ezivela eSesamum indicum, Emblica officinalis naseMomordica charantia. UPhytother Res 2000; 14: 592-5. Jonga i-abstract.
48. I-Grover JK, iVats V, iRathi SS, iDawar R.Izityalo zaseIndiya ezichasene neswekile zithintela ukuqhubela phambili komonakalo we-renal kwi-streptozotocin yeempuku zeswekile. J U-Ethnopharmacol 2001; 76: 233-8. Jonga i-abstract.
49. UVikrant V, uGrover JK, uTandon N, et al. Unyango ngezicatshulwa zeMomordica charantia kunye ne-Eugenia jambolana kuthintela i-hyperglycemia kunye ne-hyperinsulinemia kwiigundane ezondliweyo ze-fructose. J U-Ethnopharmacol 2001; 76: 139-43. Jonga i-abstract.
50. ULee-Huang S, uHuang PL, uNara PL, et al. Imephu ye-30: intsholongwane entsha yosulelo kunye nokuphindaphinda. IINKCUKACHA Lett 1990; 272: 12-8. Jonga i-abstract.
51. ULee-Huang S, uHuang PL, uHuang PL, et al. Ukuthintela ukudityaniswa kwentsholongwane (i-HIV) yohlobo loku-1 ziiprotein zezityalo ezichasene ne-HIV MAP30 kunye ne-GAP31. Iproc Natl Acad Sci U S A 1995; 92: 8818-22. Jonga i-abstract.
52. UJiratchariyakul W, iWiwat C, uVongsakul M, et al. Intsholongwane kaGawulayo kwi-Thai gourd. IPlanta Med 2001; 67: 350-3. Jonga i-abstract.
53. I-Bourinbaiar AS, i-Lee-Huang S. Umsebenzi weeprotein ze-antiretroviral ezivela kwizityalo MAP30 kunye ne-GAP31 ngokuchasene neherpes simplex virus in vitro. I-Biochem Biophys Res Commun 1996; 219: 923-9. Jonga i-abstract.
54. ISchreiber CA, Wan L, iLanga Y, et al. Iiarhente zokulwa intsholongwane, i-MAP30 kunye ne-GAP31, ayinetyhefu kwi-spermatozoa yomntu kwaye inokuba luncedo ekuthinteleni ukuhanjiswa ngokwesondo kohlobo lwe-virus ye-immunodeficiency virus 1. Fertil Steril 1999; 72: 686-90. Jonga i-abstract.
55. UNaseem MZ, uPatil SR, uPatil SR, et al. Imisebenzi ye-Antispermatogenic kunye ne-androgenic ye-Momordica charantia (Karela) kwiigundane zealbino. J U-Ethnopharmacol 1998; 61: 9-16. Jonga i-abstract.
56. USarkar S, Pranava M, Marita R.Ukubonakaliswa kwesenzo se-hypoglycemic sikaMomordica charantia kwimodeli yezilwanyana eqinisekisiweyo yeswekile. IPhemacol Res 1996; 33: 1-4. Jonga i-abstract.
57. UCakici I, uHurmoglu C, uTunctan B, et al. Impembelelo ye-Hypoglycaemic ye-Momordica charantia ekhutshwe kwi-normoglycaemic okanye i-cyproheptadine-induced hyperglycaemic. J U-Ethnopharmacol 1994; 44: 117-21. Jonga i-abstract.
58. UAli L, uKhan AK, uMamun MI, et al. Izifundo kwiziphumo ze-hypoglycemic yeziqhamo zomgubo, imbewu, kunye nesityalo sonke seMomordica charantia kwiigundane eziqhelekileyo nezeswekile. UPlanta Med 1993; 59: 408-12. Jonga i-abstract.
59. Usuku C, uCartwright T, uProvost J, uBaley CJ. Impembelelo ye-Hypoglycaemic ye-Momordica charantia. IPlanta Med 1990; 56: 426-9. Jonga i-abstract.
60. I-Leung SO, i-Yeung HW, i-Leung KN. Imisebenzi ye-immunosuppressive yeeproteni ezimbini zokuphelisa isisu ezizimeleyo kwimbewu ye-melon ekrakra (Momordica charantia). I-Immunopharmacol 1987; 13: 159-71. Jonga i-abstract.
61. UJilka C, uStrifler B, uFortner GW, et al. Kwimisebenzi ye-vivo antitumor yemelon ekrakra (Momordica charantia). Umhlaza Res 1983; 43: 5151-5. Jonga i-abstract.
62. UCunnick JE, uSakamoto K, Chapes SK, et al. Ukwenziwa kweeseli ze-cytotoxic immune cells ezisebenzisa iprotein evela kwi-melon ekrakra (Momordica charantia). Iseli Immunol 1990; 126: 278-89. Jonga i-abstract.
63. U-Lee-Huang S, uHuang PL, u-Chen HC, et al. Imisebenzi yokulwa i-HIV kunye ne-anti-tumor ye-MAP30 ephindaphindayo evela kwi-melon ekrakra. I-Gene 1995; 161: 151-6. Jonga i-abstract.
64. I-Bourinbaiar AS, i-Lee-Huang S.Ukuchaphazeleka kwento echasene ne-HIV yeziyobisi ezichasayo, i-dexamethasone kunye ne-indomethacin, nge-MAP30, iarhente yentsholongwane evela kwimelon ekrakra. I-Biochem Biophys Res Commun 1995; 208: 779-85. Jonga i-abstract.
65. IBaldwa VS, iBhandari CM, iPangaria A, iGoyal RK. Ulingo lwezonyango kwizigulana ezinesifo seswekile esine-insulin efana nekhompawundi efumaneka kwimithombo yezityalo. Ukunyuka kukaJ Med Sci 1977; 82: 39-41. Jonga i-abstract.
66. URamadan A, et al. Iipropathi ezichasene neswekile kunye ne-phytochemistry ye-Momordica charantia L. (Cucurbitaceae). Unyango lwePhytomedicine 1996; 294.
67. USrivastava Y, Venkatakrishna-Bhatt H, Verma Y, et al. Iipropathi ze-Antidiabetic kunye ne-adaptogenic ye-Momordica charantia ekhutshwayo: Uvavanyo lokuvavanywa kunye nonyango. UPhytother Res 1993; 7: 285-9.
68. UWelihinda J, et al. Iziphumo zeMomordica charantia kukunyamezelana kweswekile ekukhuleni kwesifo seswekile. J U-Ethnopharmacol 1986; 17: 277-82 (PubMed) (Umnqamlezo) Jonga i-abstract.
69. ULeatherdale B, uPanesar RK, uSingh G, et al. Ukuphuculwa konyamezelo lweglucose ngenxa kaMomordica charantia. Br Med J (Iiklinikhi Res Ed) 1981; 282: 1823-4. Jonga i-abstract.
70. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.
71. Monographs ekusebenziseni amayeza iziyobisi zezityalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.

Ukuhlaziywa kokugqibela-11/25/2020